Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
Similar to tumor initiating cells (TICs), minimal residual disease (MRD) is capable of re-initiating tumors and causing recurrence. However, the molecular characteristics of solid tumor MRD cells and drivers of their survival have remained elusive. Here we performed dense multi-region transcriptomic...
Main Authors: | Artibani, M, Masuda, K, Hu, Z, Rauher, PC, Mallett, G, Wietek, N, Morotti, M, Chong, K, KaramiNejadRanjbar, M, Zois, CE, Dhar, S, El-Sahhar, S, Campo, L, Blagden, SP, Damato, S, Pathiraja, PN, Nicum, S, Gleeson, F, Laios, A, Alsaadi, A, Santana Gonzalez, L, Motohara, T, Albukhari, A, Lu, Z, Bast Jr., RC, Harris, AL, Ejsing, CS, Klemm, RW, Yau, C, Sauka-Spengler, T, Ahmed, AA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society for Clinical Investigation
2021
|
Similar Items
-
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
by: Mara Artibani, et al.
Published: (2021-06-01) -
Mechanistic drivers of Müllerian duct development and differentiation into the oviduct
by: Santana Gonzalez, L, et al.
Published: (2021) -
A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes
by: KaramiNejadRanjbar, M, et al.
Published: (2020) -
An evolving story of the metastatic voyage of ovarian cancer cells: Cellular and molecular orchestration of the adipose-rich metastatic microenvironment
by: Motohara, T, et al.
Published: (2018) -
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct
by: Laura Santana Gonzalez, et al.
Published: (2021-03-01)